The 2x2 Project Tags the Best and Worst of Public Health in the News
Published December 6, 2013
The 2×2 Project seeks to translate emerging public health science through compelling and timely communication in order to elevate the conversation. Thus, an inherent part of our mission is to keep current on when and how public health science is featured in the news. Some is headline-worthy, some represents the successes and shortcomings of public health. And some just makes you go, “Hmm….” Our Communicating Health and Epidemiology Fellows (CHEFs) will tag the best and worst of public health in the news every Friday. We’re covering health beyond the headlines. The writing is on the wall.
Global dementia projected to peak in 2050, according G8 Summit
T.B. FOR MY M.S.
Tuberculosis vaccine may help prevent Multiple Sclerosis
THREE STITCHES FOR $2,229.11
Soaring hospital costs lead to eye-popping bills for patients
CHEAPER THAN EXPECTED
Medicaid expansion and the subsidies for private insurance plans under the ACA are projected to be billions of dollars less expensive than originally expected
PAY TO PLAY FOR PHARMA?
Invite-only meeting with the FDA? $35,000. Influencing future policy? Priceless
DENTISTS PRESCRIBE CANDY
A new sugar-free candy contains a good bacteria that significantly reduced the amount of bad bacteria in 75% of the testers
GAS MAN, MD
Why is the incidence of substance abuse disorders so high among anesthesiology residents?
National pregnancy rate reaches 12-year low, notably among teens
Pharmaceutical giant Pfizer to enhance access to data from their clinical trials
PROTECTION IN QUESTION
Questions surround an order by a British Court of Protection that forced a
bipolar woman to have a cesarean section and give her baby up for
EXTRA! ECSTASY! READ ALL ABOUT IT
ER visits related to ecstasy use have more than doubled over the last 6 years
29,000 Americans able to enroll in Healthcare.gov over 2 days
WATCH US GROW
Interactive CDC map shows Americans getting bigger over 25 years
HEP C HELP ON THE WAY
FDA set to approve gentler Hepatitis C drug